Xiaolei Zhou

karolinska institutet

H指数:18

被引数:1,292

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Co-exposure of polystyrene nanoplastics and ozone synergistically induced airway inflammation: Evidence and biomarkers screening

聚苯乙烯纳米塑料与臭氧的共暴露协同诱导了气道炎症：证据与生物标志物筛选

Ecotoxicology and Environmental Safety

IF6.1

2025-07-100

PRE

Revealing the Molecular Mechanisms of Ozone-Induced Pulmonary Inflammatory Injury: Integrated Analysis of Metabolomics and Transcriptomics

揭示臭氧诱导的肺炎性损伤的分子机制：代谢组学与转录组学的整合分析

TOXICS

IF4.1

2025-04-020

Assessment model of ozone pollution based on SHAP-IPSO-CNN and its application

基于SHAP-IPSO-CNN的臭氧污染评价模型及其应用

SCIENTIFIC REPORTS

IF3.9

2025-01-270

OAAI

NLRP3 inflammasome-mediated disruption of mitochondrial homeostasis in alveolar macrophages contributes to ozone-induced acute lung inflammatory injury

NLRP3炎性小体介导的肺泡巨噬细胞线粒体稳态破坏，参与了臭氧诱导的急性肺损伤性炎症。

ACTA BIOCHIMICA ET BIOPHYSICA SINICA

IF3.4

2024-10-170

Mesenchymal stem cell therapy for liver fibrosis need partner: Results based on a meta-analysis of preclinical studies

WORLD JOURNAL OF GASTROENTEROLOGY

IF5.4

2024-08-281

OAAI

Progress of mesenchymal stem cells (MSCs) & MSC-Exosomes combined with drugs intervention in liver fibrosis

BIOMEDICINE & PHARMACOTHERAPY

IF7.5

2024-07-012

OAAI

Fatty acids metabolism in ozone-induced pulmonary inflammatory injury: Evidence, mechanism and prevention

SCIENCE OF THE TOTAL ENVIRONMENT

IF8

2024-07-012

PRE

Transcriptome analysis reveals PRKCA as a potential therapeutic target for overcoming cisplatin resistance in lung cancer through ferroptosis

转录组分析揭示PRKCA是通过铁死亡克服肺癌顺铂耐药的潜在治疗靶点

HELIYON

IF3.6

2024-05-016

OAAI

Study on metal recovery process and kinetics of oxidative leaching from spent LiFePO4 Li-batteries

废旧LiFePO4锂电池金属回收工艺及氧化浸出动力学研究

CHINESE JOURNAL OF CHEMICAL ENGINEERING

IF3.7

2024-04-011

PRE

Translating p53-based therapies for cancer into the clinic

将基于p53的癌症疗法转化为临床应用

NATURE REVIEWS CANCER

IF66.8

2024-01-2930

PRE

Mutant p53 gain of function mediates cancer immune escape that is counteracted by APR-246

BRITISH JOURNAL OF CANCER

IF6.8

2022-09-2214

OAAI

Decreased DNA Damage and Improved p53 Specificity of RITA Analogs

MOLECULAR CANCER THERAPEUTICS

IF5.5

2022-07-253

Neutrophil-Dependent Immunity During Pulmonary Infections and Inflammations

FRONTIERS IN IMMUNOLOGY

IF5.9

2021-10-1926

OAAI

Pharmacologic Activation of p53 Triggers Viral Mimicry Response Thereby Abolishing Tumor Immune Evasion and Promoting Antitumor Immunity

CANCER DISCOVERY

IF33.3

2021-07-06106

OAAI

Identification and targeting of selective vulnerability rendered by tamoxifen resistance

BREAST CANCER RESEARCH

IF5.6

2020-07-2911

OAAI

In vitro and in vivo antiviral characterization of RO7049389, a novel small molecule capsid assembly modulator for the treatment of chronic hepatitis B

JOURNAL OF HEPATOLOGY

IF33

2018-04-019

PREAI

An ELISA method detecting the active form of suPAR

TALANTA

IF6.1

2016-11-0110

PREAI

A drug carrier targeting murine uPAR for photodynamic therapy and tumor imaging

ACTA BIOMATERIALIA

IF9.6

2015-09-0119

PREAI

Dual actions of albumin packaging and tumor targeting enhance the antitumor efficacy and reduce the cardiotoxicity of doxorubicin in vivo

INTERNATIONAL JOURNAL OF NANOMEDICINE

IF6.5

2015-08-0126

OAAI

Common variants in human CRC genes as low-risk alleles

EUROPEAN JOURNAL OF CANCER

IF7.1

2010-04-0168

PREAI

Xiaolei Zhou

个人简介

教育背景

工作经历

荣誉奖项

研究方向